A Scientific Insight into Step by Step Procedures for the Prediction of Cytochrome Enzyme Oriented Herb-Drug Interactions

Dhivya Dhanasekaran, Nila Ganamurali, Sarvesh Sabarathinam*

SRM College of Pharmacy, SRM IST, Kattankulathur, kancheepuram, Tamil Nadu, India.

Abstract: Background: Herbs are widely used by majority of the patient for their chronic illness at least once in their life time. Liver enzymes play a major role in the metabolism of xenobiotics. In vivo & In vitro technique prediction of drug interaction is widely practiced. Method: Since there is no standard database for the prediction of herb-drug interaction. Abroad literature survey is carried out to ensure the process of prediction of herb-drug interaction from the various databases. For the prediction of herb-drug interaction step by step, strategy is enumerated in this review. Discussion: The drug interaction potential of targeted drug estimated by in silico, in vitro, in vivo animal model and phase one trial. CYP450 enzyme inhibition potential was assessed using High throughput screening assay followed by drug binding affinities measured through in silico studies. Conclusion: This study gives the step-by-step approach to analyzing the drug interaction potential herbal medicine with CYP450 enzymes.


Keywords:CYP450, Healthy volunteers, Herb-drug interaction, In vivo, In vitro, In silico, Probe drug.

DOWNLOAD PDF

References:
  1. Sarvesh S, Raja MK, Rajanandh MG, Seenivasan P. Prevalence and pattern of usage of complementary and alternative medicine among south Indian asthma patients in a tertiary care hospital. Complement Ther Clin Pract 2018; 30: 103-8.
  2. Shrilatha KJM, Harini RR, Kaaviya AA, Sabarathinam S, Madhana Kumar S. Prevalence and pattern of use of complementary and alternative medicine in diabetes patients in a south Indian tertiary care teaching hospital. Drug Invent Today 2019; 11: 274-9.
  3. Raja BY, Simon MA, Jayakumar KT, Sarvesh S. Patient knowledge survey in a multi-speciality hospital. Int J Community Med Public Health 2019; 6: 1221-4.
  4. Sabarathinam S, Palanichamy S, Ramakrishnan SR, Muhasaparur R, Ganesan MU. Prevalence of metabolic syndrome in diabetic patients attending a diabetic clinic in a tertiary care hospital. Drug Invent Today 2019; 12: 1395-8.
  5. Na DH, Ji HY, Park EJ, Kim MS, Liu K-H, Lee HS. Evaluation of metabolism-mediated herb-drug interactions. Arch Pharmacal Res 2011; 34: 1829-42.
  6. Hu SX, Mazur CA, Feenstra KL. Assessment of Inhibition of Bovine Hepatic Cytochrome P450 by 43 Commercial Bovine Medicines Using a Combination of In Vitro Assays and Pharmacokinetic Data from the Literature. Drug Metab Lett 2019;13:123-31.
  7. Rishabh Kaushik SK, Sharma M, Srinivasan Hemalatha, Zeba Mueed, Poddar NK. Role of Cytochrome P450 in Prostate Cancer and its Therapy. Curr Enzym Inhib 2020; 16: 63.
  8. Poonam Giri HP, Srinivas NR. Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies – Review of Case Studies. Drug Metab Lett 2019; 13: 3-18.
  9. Halama B, Hohmann N, Burhenne J, Weiss J, Mikus G, Haefeli WE. A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions. Clin Pharmacol Ther 2013; 93: 564-71.
  10. Sabarathinam S, Vijayakumar TM. Estimation of E-guggulsterone, Z-guggulsterone and myrcene in Mahayograj Guggul tablet by high- performance thin-layer chromatography (HPTLC) method: A marketed herbal formulation. Drug Invent Today 2020; 11: 270.
  11. Sabarathinam S, Vijayakumar TM. RP-HPLC Method Development and Validation of Midazolam: A CYP3A4 Probe Drug. Res J Pharm Technol 2020; 13: 3565-8.
  12. Sabarathinam S, Vijayakumar TM. A short exploration of selected sensitive CYP3A4 substrates (Probe Drug). Drug metab lett 2020.
  13. Zhang YT, Zhang DF, Ge NY, Zhu GH, Hao C, Zhang Y, et al. Effect of Evodiamine on CYP Enzymes in Rats by a Cocktail Method. Pharmacology 2016;97:218-23.
  14. Han YL, Li D, Ren B, Jing GP, Meng XL, Zhou ZY, et al. Evaluation of impact of Herba Erigerontis injection, a Chinese herbal prescription, on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. J Ethnopharmacol 2012;139:104-9.
  15. Wei Y-L, Du H-J, Lin Y-P, Wu M-L, Xu R-A. Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs. Iran J Basic Med Sci 2018;21:422-6.
  16. Zhou C-j, Qiao L-m, Zhao L-h, Li Z-y. Evaluation of the impact of cantharidin on rat CYP enzymes by using a cocktail of probe drugs. Fitoterapia 2015;107:49-53.
  17. Geng P, Wang S, Wang C, Chen J, Zhang L, Yang S, et al. Evaluation of the impact of Flos Daturae on rat hepatic cytochrome P450 enzymes by cocktail probe drugs. Int J Clin Exp Med 2015;8:22310-8.
  18. Showande SJ, Fakeye TO, Kajula M, Hokkanen J, Tolonen A. Potential inhibition of major human cytochrome P450 isoenzymes by selected tropical medicinal herbs-Implication for herb-drug interactions. Food Sci Nutr 2018;7:44-55.
  19. Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci. 2006;78:2105-15.
  20. Ferdousi R, Safdari R, Omidi Y. Computational prediction of drug-drug interactions based on drugs functional similarities. J Biomed Inform 2017;70:54-64.
  21. Li Z, Han P, You ZH, Li X, Zhang Y, Yu H, et al. In silico prediction of drug-target interaction networks based on drug chemical structure and protein sequences. Sci Rep 2017;7:11174.
  22. Yang H, Sun L, Wang Z, Li W, Liu G, Tang Y. ADMETopt: A Web Server for ADMET Optimization in Drug Design via Scaffold Hopping. J Chem Inf Model 2018;58:2051-6.
  23. Fisher CD, Lickteig AJ, Augustine LM, Ranger-Moore J, Jackson JP, Ferguson SS, et al. Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease. Drug Metab Dispos 2009;37:2087-94.
  24. Teo YL, Ho HK, Chan A. Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations. Br J Clin Pharmacol 2015;79:241-53.
  25. Williams D, Tao X, Zhu L, Stonier M, Lutz JD, Masson E, et al. Use of a cocktail probe to assess potential drug interactions with cytochrome P450 after administration of belatacept, a costimulatory immunomodulator. Br J Clin Pharmacol 2017;83:370-80.
  26. Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res 2008;52:755-63.
  27. Doroshyenko O, Rokitta D, Zadoyan G, Klement S, Schläfke S, Dienel A, et al. Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers. Drug Metab Dispos 2013;41:987-93.
  28. Malati CY, Robertson SM, Hunt JD, Chairez C, Alfaro RM, Kovacs JA, et al. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol 2012;52:932-9.
  29. Tan ML, Lim LE. The effects of Andrographis paniculata (Burm.f.) Nees extract and diterpenoids on the CYP450 isoforms' activities, a review of possible herb-drug interaction risks Drug Chem Toxicol 2015;38:241-53.
  30. Chen XW, Sneed KB, Pan SY, Cao C, Kanwar JR, Chew H, et al. Herb-drug interactions and mechanistic and clinical considerations. Curr Drug Metab 2012;13:640-51.